-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, AzaaN2hWCteGVS2jiIjvYAeIFZXEG2d+ugXmmDIIU9hip0xqgVgZlSdl4I6I7xrv U7llSfGfbAW1M02qWENp1Q== 0000950115-98-000933.txt : 19980514 0000950115-98-000933.hdr.sgml : 19980514 ACCESSION NUMBER: 0000950115-98-000933 CONFORMED SUBMISSION TYPE: S-8 PUBLIC DOCUMENT COUNT: 5 FILED AS OF DATE: 19980513 EFFECTIVENESS DATE: 19980513 SROS: AMEX FILER: COMPANY DATA: COMPANY CONFORMED NAME: BLONDER TONGUE LABORATORIES INC CENTRAL INDEX KEY: 0001000683 STANDARD INDUSTRIAL CLASSIFICATION: RADIO & TV BROADCASTING & COMMUNICATIONS EQUIPMENT [3663] IRS NUMBER: 521611421 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-8 SEC ACT: SEC FILE NUMBER: 333-52519 FILM NUMBER: 98617922 BUSINESS ADDRESS: STREET 1: ONE JAKE BROWN RD STREET 2: PO BOX 1000 CITY: OLD BRIDGE STATE: NJ ZIP: 08857 BUSINESS PHONE: 9086794000 MAIL ADDRESS: STREET 1: ONE JAKE BROWN ROAD CITY: OLD BRIDGE STATE: NJ ZIP: 08857 S-8 1 FORM S-8 REGISTRATION STATEMENT As filed with the Securities and Exchange Commission on May 13, 1998 Registration No.______________ ================================================================================ SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 -------------------------- FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 -------------------------- BLONDER TONGUE LABORATORIES, INC. (Exact name of registrant as specified in its charter) Delaware 52-1611421 (State or other jurisdiction of (I.R.S. Employer incorporation or organization) Identification Number) One Jake Brown Road Old Bridge, New Jersey 08857 (732) 679-4000 (Address, including zip code, and telephone number, including area code, of registrant's principal executive offices) BLONDER TONGUE LABORATORIES, INC. 1995 LONG TERM INCENTIVE PLAN (Full title of each Plan) James A. Luksch President and Chief Executive Officer One Jake Brown Road Old Bridge, New Jersey 08857 (732) 679-4000 (Name, address, including zip code, and telephone number, including area code, of agent for service) -------------------------- Copies to: Gary P. Scharmett, Esquire Stradley, Ronon, Stevens & Young, LLP 2600 One Commerce Square Philadelphia, Pennsylvania 19103-7098 --------------------------
- ----------------------------------------------------------------------------------------------------------------------------- CALCULATION OF REGISTRATION FEE - ----------------------------------------------------------------------------------------------------------------------------- Proposed maximum Proposed maximum Amount to be offering price per aggregate offering Amount of Title of securities to be registered registered(1) Share price (4) registration fee - ----------------------------------------------------------------------------------------------------------------------------- Common Stock, $.001 par value per share 204,500 shares $ 8.63 (2) $5,841,800 $1,723.33 ---------- --------- 60,000 shares $ 12.69 (2) 10,000 shares $ 15.13 (2) 300,500 shares $ 10.53 (3) ------------ - -----------------------------------------------------------------------------------------------------------------------------
(1) Such additional, indeterminable number of shares that may be issuable by reason of the anti-dilution provisions of the Blonder Tongue Laboratories, Inc. 1995 Long Term Incentive Plan, as amended (the "1995 Plan") and the Blonder Tongue Laboratories, Inc. Amended and Restated 1996 Director Option Plan (the "1996 Plan," and together with the 1995 Plan, the "Plans") are hereby registered. (2) Pursuant to Rule 457(h)(1), for shares issuable under presently outstanding options granted under the 1995 Plan, the price at which such options may be exercised has been used to determine the registration fee. (3) Pursuant to Rule 457(h)(1) and (c), for shares available under the Plans that have yet to be granted or are not presently subject to outstanding options, the average of the high and low prices per share of the Common Stock reported on the American Stock Exchange on May 11, 1998 has been used to determine the registration fee. (4) Estimated solely for the purpose of determining the registration fee. Pursuant to General Instruction E to Form S-8, the contents of the Company's Registration Statement on Form S-8 (Registration No. 333-15039) originally filed with the Securities and Exchange Commission on October 29, 1996 (the "Prior Registration Statement") are incorporated herein by reference, except for (i) Items 3, 5 and 8 of Part II of the Prior Registration Statement and (ii) the Reoffer Prospectus. This Registration Statement covers 500,000 shares which, together with 250,000 shares under the Prior Registration Statement constitute the 750,000 shares issuable under the Company's 1995 Long Term Incentive Plan, as amended. This Registration Statement also covers 75,000 shares, which together with the 25,000 shares under the Prior Registration Statement, constitute the 100,000 shares of common stock issuable under the Company's Amended and Restated 1996 Director Option Plan. -2- PART II INFORMATION REQUIRED IN REGISTRATION STATEMENT Item 3. Incorporation of Documents by Reference. The following documents, previously filed by the Company with the Commission pursuant to the Securities Exchange Act of 1934, as amended (the "1934 Act"), are hereby incorporated by reference in this Registration Statement, except as superseded or modified herein: (a) the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 1997; (b) all other reports filed by the Company pursuant to Section 13(a) or 15(d) of the 1934 Act since the end of the fiscal covered by the annual report referred to above; and (c) the description of the Common Stock contained in the Company's Registration Statement on Form S-1 (Registration No. 33-98070) originally filed with the Commission on October 12, 1995, including any amendments or reports filed for the purpose of updating such description. All documents filed by the Company pursuant to Sections 13(a), 13(c), 14 and 15(d) of the 1934 Act on or after the date of this Registration Statement and prior to the filing of a post-effective amendment which indicates that all securities offered have been sold or which deregisters all securities then remaining unsold, shall be deemed to be incorporated by reference in this Registration Statement and to be part hereof from the date of filing of such documents. Item 5. Interest of Named Experts and Counsel. Stradley, Ronon, Stevens & Young, LLP ("SRSY"), legal counsel to the Company, has offered its opinion upon the legality of the Common Stock. Certain attorneys at SRSY own an aggregate of approximately 11,500 shares of the Company's Common Stock. Gary P. Scharmett, a partner of the firm, is a director of the Company, and holds an option to purchase 10,000 shares of the Common Stock at a purchase price of $10.25 per share, which option may be exercised for a 10-year period ending on July 16, 2006. Item 8. Exhibits. Reference is made to the Exhibit Index on page II-3 filed herewith. II-1 SIGNATURES Pursuant to the requirements of the Securities Act of 1933, the registrant Blonder Tongue Laboratories, Inc. certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Old Bridge, State of New Jersey, on May 11, 1998. BLONDER TONGUE LABORATORIES, INC. By: \s\ James A. Luksch --------------------------------- James A. Luksch, President and Chief Executive Officer Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed below by the following persons in the capacities and on the dates indicated. Each person whose signature appears below constitutes and appoints James A. Luksch and Robert J. Palle, Jr., jointly and severally, his attorneys-in-fact, each with the power of substitution, for him in any and all capacities to sign any amendments to this Registration Statement on Form S-8, and to file the same, with exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, hereby ratifying and confirming all that each of said attorneys-in-fact, or his substitute or substitutes, may do or cause to be done by virtue hereof.
Name Title Dates - ---- ----- ----- \s\ James A. Luksch Director, President and May 11, 1998 - ------------------------------------- Chief Executive Officer James A. Luksch (Principal Executive Officer) \s\ Peter Pugielli Senior Vice President - Finance, May 11, 1998 - ------------------------------------- Treasurer and Chief Financial Officer Peter Pugielli (Principal Financial Officer and Principal Accounting Officer) \s\ Robert J. Palle, Jr. Director, Executive Vice May 11, 1998 - ------------------------------------- President and Chief Operating Officer Robert J. Palle, Jr. \s\ James H. Williams Director May 11, 1998 - ------------------------------------- James H. Williams \s\ James F. Williams Director May 11, 1998 - ------------------------------------- James F. Williams \s\ Robert B. Mayer Director May 11, 1998 - ------------------------------------- Robert B. Mayer \s\ John E. Dwight Director May 11, 1998 - ------------------------------------- John E. Dwight \s\ Gary P. Scharmett Director May 11, 1998 - ------------------------------------- Gary P. Scharmett \s\ Robert E. Heaton Director May 11, 1998 - ------------------------------------- Robert E. Heaton
II-2
EXHIBIT INDEX Exhibit # Description Sequential Page Number - --------- ----------- ---------------------- 4.1 Blonder Tongue Laboratories, Inc. 1995 Incorporated by reference from Long Term Incentive Plan (the "1995 Plan") Exhibit 10.6 to S-1 Registration Statement No. 33-98070 originally filed on October 12, 1995, as amended. 4.2 First Amendment to the 1995 Plan Incorporated by reference from Exhibit 10.5(a) to Registrants Quarterly Report on Form 10-Q for the period ended March 31, 1997. 4.3 Second Amendment to the 1995 Plan Filed herein. 4.4 Blonder Tongue Laboratories, Inc. Filed herein. Amended and Restated 1996 Director Option Plan 5.1 Opinion of Counsel as to Legality of Filed herein. Securities Being Registered 23.1 Consent of Counsel Contained in Exhibit 5.1, filed herein. 23.2 Consent of BDO Seidman, LLP Filed herein. 24.1 Power of Attorney Contained in Signature Page herein. II-3
EX-4.3 2 1995 LONG-TERM INCENTIVE PLAN Exhibit 4.3 SECOND AMENDMENT TO BLONDER TONGUE LABORATORIES, INC. 1995 LONG TERM INCENTIVE PLAN The Blonder Tongue Laboratories, Inc. 1995 Long Term Incentive Plan, as heretofore amended (the "Plan"), is hereby amended as follows: 1. The first sentence of Section 3.1 of the Plan is hereby amended and restated in its entirety as follows: "Subject to adjustment pursuant to the provisions of Section 3.2 hereof, the number of shares of Stock of the Company which may be issued and sold or awarded under the Plan shall not exceed 750,000 shares, of which shares issued and sold pursuant to Incentive Stock Options under the Plan shall not exceed 725,000 and shares subject to restricted stock awards may not exceed 25,000." 2. Ratification. Except as expressly set forth in this Second Amendment to the Plan, the Plan is hereby ratified and confirmed without modification. 3. Effective Date. The effective date of this Second Amendment to the Plan shall be September 3, 1997. EX-4.4 3 AMENDED AND RESTATED 1996 DIRECTOR OPTION PLAN EX-4.4 BLONDER TONGUE LABORATORIES, INC. AMENDED AND RESTATED 1996 DIRECTOR OPTION PLAN 1. DEFINITIONS As used herein, the following terms shall have the meanings hereinafter set forth unless the context clearly indicates to the contrary: 1.1 "Agreement" - The agreement between the Company and the Optionee under which the Optionee may purchase Stock pursuant to the Plan. 1.2 "Board" - The Board of Directors of the Company. 1.3 "Company" - Blonder Tongue Laboratories, Inc., a Delaware corporation. 1.4 "Code" - The United States Internal Revenue Code of 1986, as from time to time amended. 1.5 "Eligible Director" - Any person who is a member of the Board and neither is currently, nor within the past six (6) months was employed by the Company or any subsidiary of the Company. 1.6 "Fair Market Value" - The per share fair market value of the Stock of the Company, determined by taking the mean average of the high and low selling price as reported by the principal national exchange upon which such shares are traded (or if not traded on a national exchange then the mean average between the bona fide closing bid and ask prices) (the "Trading Price") on the date of grant, or if none, by taking a weighted average of the means of the Trading Price on the nearest trading date before and the nearest trading date after the date of grant. 1.7 "Option" - An option to purchase Stock of the Company granted pursuant to the provisions of the Plan. All Options shall be non-statutory stock options within the meaning of the Code. 1.8 "Optionee" - The person to whom an Option has been granted pursuant to the provisions of the Plan. 1.9 "Option Price" - The per share exercise price of the Stock with respect to which an Option has been granted under the Plan. 1.10 "Plan" - The Company's Amended and Restated 1996 Director Option Plan, the terms of which are set forth herein. 1.11 "Stock" - The common stock of the Company. 2. ESTABLISHMENT AND PURPOSE OF PLAN 2.1 Establishment and Purpose of Plan. The Company hereby establishes the Plan for the purpose of encouraging equity ownership in the Company by outside directors of the Company whose continued services are considered essential to the Company's sustained progress, and thus to provide them with a further incentive to continue as directors of the Company. 2.2 Effective Date of Plan. The effective date of the Plan was originally January 1, 1996. The Plan, as amended and restated herein, shall be effective on December 18, 1997, subject to stockholder approval, with respect to grants made after such date. 2.3 Expiration of the Plan. The Plan shall terminate at the close of business on January 2, 2006, or such earlier date as the Board may determine pursuant to Section 7 of the Plan, and no Option shall be granted after that date. 3. STOCK SUBJECT TO PLAN 3.1 Limitations. Subject to adjustment pursuant to the provisions of Section 3.2 hereof, the number of shares of Stock of the Company which may be issued and sold under the Plan shall not exceed 100,000 shares. 3.2 Adjustments. a. Anti-Dilution. If the outstanding shares of Stock of the Company are hereafter changed or converted into or exchanged or exchangeable for a different number or kind of shares or other securities of the Company or of another corporation by reason of a reorganization, merger, consolidation, recapitalization, reclassification, combination of shares, stock dividend, stock split or reverse stock split, appropriate adjustment shall be made in the number of shares and kind of stock which may be granted as provided in Section 3.1, and subject to unexercised Options, to the end that the proportionate interest of Optionee's shall be maintained as before the occurrence of such event. b. Non-survival of Company. In the event of a dissolution or liquidation of the Company or any merger or combination in which the Company is not a surviving corporation, each outstanding Option granted hereunder shall terminate, but the Optionee shall have the right, immediately prior to such liquidation, dissolution, merger or combination, to exercise his Option, in whole or in part, to the extent that such Option is then otherwise exercisable and has not previously been exercised; provided, however, that in the event of any such dissolution, liquidation, merger or combination, the Board may modify any Options granted hereunder so as to accelerate as a consequence of such transaction the Optionee's right to exercise any such Option. c. Change of Control. In the event of any contemplated transaction which may constitute a change of control of the Company, the Board may modify any Options granted hereunder so as to accelerate, as a consequence of such transaction, the Optionee's right to exercise any such Option. A Change of Control is that change in control of the Company which is of a nature which would be required to be reported to the Securities and Exchange Commission pursuant to Schedule 14A of Regulation 14A or any successor provision (whether or not the Company is then subject to such reporting requirements). A Change of Control will be deemed to have occurred for purposes of this plan if any person, other than persons or entities who on the date hereof are the "beneficial owners" (as determined pursuant to Sections 13(d) and 14(d) of the Securities Exchange Act of 1934), directly or indirectly, of securities of the Company representing 10% or more of the combined voting power of the Company's then outstanding securities, is or becomes the "beneficial owner" of 25% or more of the combined voting power of the outstanding securities of the Company or if during two consecutive year periods, the directors at the beginning of such periods cease for any reason during the two-year period to constitute a majority of the Board of Directors of the Company. 3.3 Effect of Exercise or Termination of Option. Shares of Stock with respect to which an Option granted under the Plan shall have been exercised shall not again be available for grant under the Plan. If Options granted under the Plan shall terminate for any reason without being wholly exercised, new Options may be granted under the Plan covering that number of shares of Stock with respect to which such termination relates. 2 4. ADMINISTRATION OF THE PLAN 4.1 Administration by the Board. Subject to the provisions of the Plan, the Plan shall be administered by the Board. 4.2 Powers and Duties. The Board shall have sole discretion and authority to determine the Eligible Directors to whom Options shall be granted. Except as otherwise provided in the Plan, the Board shall have sole discretion and authority to interpret the Plan, to prescribe, amend and rescind rules and regulations relating to the Plan, to determine the details and provisions of each Agreement executed pursuant to the Plan, and to make all other determinations necessary or advisable in the administration of the Plan. 4.3 Quorum and Majority Rule. A majority of the then members of the Board shall constitute a quorum and any action taken by a majority present at a meeting at which a quorum is present or any action taken without a meeting evidenced by a writing executed by all of the members of the Board, as the case may be, shall constitute the action of the Board. 4.4 Liability of the Board. No member of the Board shall be liable for any action, determination or interpretation under any provision of the Plan or otherwise if such action, determination or interpretation was done or made in good faith by such member of the Board. 5. OPTIONS GRANTED UNDER THE PLAN 5.1 Grant of Options. Options shall be granted only to Eligible Directors. An Eligible Director may be granted one or more Options; provided, however, that no Eligible Director shall be granted Options to purchase more than 5,000 shares of stock in any one calendar year. Each Option granted under the Plan shall be evidenced by an Agreement dated as of the date such Option is granted. The Agreement shall contain such terms and conditions as shall be determined by the Board, consistent with the Plan. 5.2 Vesting. Each Option shall vest and be exercisable at such time or times as determined by the Board on the date of grant. 5.3 Option Price. The Option Price of the Stock subject to each Option shall be the Fair Market Value of the Stock on the date the Option is granted. 5.4 Option Exercise Period. The period during which any Option granted under the Plan may be exercised shall be not more than ten years from the date of grant, as determined by the Board, which period shall be set forth in the Agreement. 5.5 Option Exercise. An Option granted pursuant to the Plan may be exercised at any time or times, specified in the Agreement, prior to the termination of the said Option by delivery by the Optionee of written notice to the Company specifying the number of shares of Stock to be purchased accompanied by full payment for such shares of Stock. The right of exercise shall be cumulative. Full payment shall be in cash, or at the discretion of the Board, a. the option price of any Option may be paid in shares of Stock of the Company; or b. the option price may be paid by withholding that number of shares subject to the Option whose aggregate fair market value at the date of exercise equals the Option Price. In addition, sufficient shares subject to the Option (valued at the fair market value thereof at such date) may also be withheld to pay any Federal, state or local tax due on account of the exercise of the Option. 5.6 Termination of Option. a. Termination of Service on the Board. Except as specifically provided in Section 3.2(b) and Sections 5.6(b) and 5.6(c) hereof, the Options granted hereunder shall terminate as of the close of 3 business on the earliest to occur of the date of (i) expiration of the Option Exercise Period provided in Section 5.4 hereof, (ii) an event of default or breach by an Optionee of the terms and conditions of such Optionee's Agreement, or (iii) termination of an Optionee's service on the Board for cause. If an Optionee's service on the Board is terminated other than for cause, death (as provided in subsection (b) below), or retirement or disability (both as provided in subsection (c) below), the Optionee must exercise his Option, if at all and only to the extent the option is exercisable at termination, within thirty six months after the date of such termination, in accordance with the terms of the Plan and the Agreement. b. Death of Optionee. If an Optionee dies prior to the exercise of his Option in full, his Option may be exercised by the Optionee's executors, administrators or heirs within one year after the date of the Optionee's death, provided such death occurred during the Optionee's service on the Board, or within three months following the termination of such service by reason of the Optionee's retirement after reaching the age of 65 years or the Optionee's retirement after becoming permanently disabled. Such Option may be so exercised by the Optionee's executors, administrators or heirs only with respect to that number of shares of Stock which the Optionee had an Option to purchase and which Option was exercisable (but had not theretofore been exercised) as of the date of the earlier of the (i) retirement of the Optionee after reaching the age of 65 years or after becoming permanently disabled, or (ii) death of the Optionee. In no event may the Option be exercised at any time after the expiration of the Option Exercise Period set forth in Section 5.4 hereof. c. Retirement or Disability. If an Optionee's service on the Board is terminated prior to the exercise of his Option in full, by reason of the Optionee's retirement after reaching the age of 65 years or by reason of the Optionee's retirement after becoming permanently disabled, the Optionee shall have the right, during the period ending thirty-six months after the date of his termination of service on the Board, to exercise his Option. Such Option may be exercised by the Optionee only with respect to that number of shares of Stock which the Optionee had an Option to purchase and which Option was exercisable (but had not theretofore been exercised) as of the date of the earlier of (i) the retirement of the Optionee after reaching the age of 65 years, or (ii) the date the Optionee becomes permanently disabled. In no event may the Option be exercised at any time after the expiration of the Option Exercise Period set forth in Section 5.4 hereof. 5.7 Nontransferability of Options. No Option granted pursuant to the Plan may be transferred by an Optionee. Subject to the provisions of Section 5.6(b) hereof, the Option shall be exercisable only by an Optionee during his lifetime. 5.8 Rights as Stockholder. An Optionee shall have no rights as a stockholder of the Company with respect to any shares of Stock subject to an Option prior to his purchase of such shares of Stock by exercise of such Option as provided in the Plan. 5.9 Right as a Director. Neither the Plan, nor the granting of an Option hereunder, nor any other action taken pursuant to the Plan, shall constitute or be evidence of any agreement or undertaking, express or implied, that the Company will retain any director for any period of time, or at any particular rate of compensation, or with any other benefits whatsoever. 6. DELIVERY OF STOCK CERTIFICATES 6.1 The Company shall not be required to issue or deliver any certificate for shares of Stock purchased upon the exercise of all or any portion of any Option granted under the Plan prior to the fulfillment of any of the following conditions which may, from time to time, be applicable to the issuance of the Stock: a. Listing of Shares. The admission of such shares of Stock to listing on (i) all stock exchanges on which the Stock of the Company is then listed or (ii) the NASDAQ. b. Registration and/or Qualification of Shares. The completion of any registration or other qualification of such shares of Stock under any federal or state securities laws or under the regulations promulgated by the Securities and Exchange Commission or any other federal or state governmental regulatory body, which the Board shall deem necessary or advisable. The Company shall in no event be obligated to 4 register any securities pursuant to the Securities Act of 1933, as amended, or to take any other action in order to cause the issuance and delivery of such certificates to comply with any such law, regulations or requirement. c. Approval or Clearance. The obtaining of any approval or clearance from any federal or state governmental agency which the Board shall determine to be necessary or advisable. d. Reasonable Lapse of Time. The lapse of such reasonable period of time following the exercise of the Option as the Board may establish from time to time for reasons of administrative convenience. 7. TERMINATION, AMENDMENT AND MODIFICATION OF PLAN 7.1 The Board may terminate the Plan at any time or amend or modify the Plan at any time or from time to time, provided, however, that no such action of the Board shall do any of the following: a. Increase Number of Shares. Except as contemplated in Section 3.2 of the Plan, increase the total number of shares of Stock subject to the Plan without the approval of stockholders. b. Change Terms of Outstanding Options. Modify the requirements for eligibility for participation, or change the Option Price or otherwise alter or impair any Option previously granted to an Optionee under the Plan without the consent of the Optionee. c. Increase Benefits. Materially increase the benefits accruing to Eligible Directors with respect to Options granted under the Plan without the approval of stockholders. d. Continue Plan. Continue the Plan in effect beyond January 2, 2006, without the approval of stockholders. 8. MISCELLANEOUS 8.1 Plan Binding on the Successors. The Plan shall be binding upon the successors and assigns of the Company. 8.2 Withholding Taxes. Whenever Federal, state and local tax is due on the exercise of Options granted under this Plan, the Company may require the Optionee to remit an amount sufficient to satisfy Federal, state and local withholding taxes prior to the delivery of any certificate for such shares. 5 EX-5.1 4 OPINION OF COUNSEL May 12, 1998 Blonder Tongue Laboratories, Inc. One Jake Brown Road Old Bridge, NJ 08857 Attention: James A. Luksch, Chairman, President and Chief Executive Officer Re: Registration Statement on Form S-8 Dear Mr. Luksch: We have acted as counsel to and for Blonder Tongue Laboratories, Inc., a Delaware corporation (the "Company"), in connection with the preparation and filing with the Securities and Exchange Commission of a registration statement on Form S-8 (the "Registration Statement"), for the purpose of registering under the Securities Act of 1933, as amended, 575,000 shares (the "Shares") of the Company's common stock, $.001 par value per share (the "Common Stock"). The Shares are issuable upon the exercise of certain options (the "Options") granted or to be granted under the Company's 1995 Long Term Incentive Plan, as amended (the "1995 Plan") and the Company's Amended and Restated 1996 Director Option Plan (the "Director Plan," and together with the 1995 Plan, the "Plans"). In our capacity as counsel, we have been requested to render the opinions set forth in this letter and, in connection therewith, we have reviewed the following documents: (i) the Registration Statement, (ii) the Plans, (iii) Restated Certificate of Incorporation of the Company, certified as true and correct by the Secretary of the Company, (iv) Bylaws of the Company, certified as true and correct by the Secretary of the Company, (v) certain minutes of meetings or unanimous consents of the Board of Directors and stockholders of the Blonder Tongue Laboratories, Inc. May 12, 1998 Page 2 Company, and (vi) the form of option agreement executed or to be executed by the Company and each optionee (the "Option Agreement"). In rendering this opinion, we have assumed and relied upon, without independent investigation, (i) the authenticity, completeness, truth and due authorization and execution of all documents submitted to us as originals, (ii) the genuineness of all signatures on all documents submitted to us as originals, and (iii) the conformity to the originals of all documents submitted to us as certified or photostatic copies. The law covered by the opinion expressed herein is limited to (a) the Federal statutes, judicial decisions and rules and regulations of the governmental agencies of the United States of America and (b) the Delaware General Corporation Law, as amended. This opinion letter is given only with respect to laws and regulations presently in effect. We assume no obligation to advise you of any changes in law or regulation which may hereafter occur, whether the same are retroactively or prospectively applied, or to update or supplement this letter in any fashion to reflect any facts or circumstances which hereafter come to our attention. Based upon, and subject to, the foregoing, we are of the opinion that the Shares covered by Options outstanding as of the date hereof, when issued upon proper exercise of the Options and payment of the exercise price, all in accordance with the terms of the Plans, will be validly issued, fully paid and nonassessable. The additional Shares covered by the Plans, when issued upon proper exercise of Options to be granted by the Compensation Committee of the Board of Directors or the Board of Directors and upon payment of the exercise price, all in accordance with the terms of the Plans, will be validly issued, fully paid and nonassessable. We hereby consent to the use of this opinion as an exhibit to the Registration Statement and we further consent to the reference to our firm under the caption "Named Experts and Counsel" in the Registration Statement and to any reference to our firm in the Registration Statement as legal counsel who have passed upon the legality of the securities offered thereby. Very truly yours, STRADLEY, RONON, STEVENS & YOUNG, LLP By: \s\ Gary P. Scharmett ---------------------------- Gary P. Scharmett, A Partner EX-23.2 5 CONSENT OF PUBLIC ACCOUNTANTS CONSENT OF INDEPENDENT CERTIFIED PUBLIC ACCOUNTANTS We hereby consent to the incorporation by reference in this Form S-8 of our report dated February 20, 1998, except for Note 16 for which the date is March 25, 1998, relating to the consolidated financial statements of Blonder Tongue Laboratories, Inc. appearing in the Company's Form 10-K for the year ended December 31, 1997. /s/ BDO Seidman, LLP - -------------------- BDO Seidman, LLP Woodbridge, NJ April 20, 1998 -----END PRIVACY-ENHANCED MESSAGE-----